Every SEC Form 3/4/5 on record for this filer (CIK 1460751) — 13 issuers, 21 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| BZFD | BuzzFeed, Inc. | 10% owner | 2021-12-07 → 2025-03-14 | 4 | −$96,303 |
| SGMT | Sagimet Biosciences Inc. | 10% owner · lapsed | 2023-07-13 → 2024-01-31 | 3 | — |
| UTRS | MINERVA SURGICAL INC | 10% owner · lapsed | 2021-10-21 → 2023-02-10 | 3 | — |
| PHAS | PhaseBio Pharmaceuticals Inc | 10% owner · lapsed | 2018-10-17 → 2022-10-26 | 3 | — |
| COUR | Coursera, Inc. | 10% owner · lapsed | 2021-03-30 → 2021-05-21 | 3 | — |
| SPT | Sprout Social, Inc. | 10% owner · lapsed | 2019-12-12 → 2020-11-17 | 4 | — |
| NET | Cloudflare, Inc. | 10% owner · lapsed | 2019-09-12 → 2020-11-13 | 5 | — |
| RARX | Ra Pharmaceuticals, Inc. | 10% owner · lapsed | 2016-10-25 → 2020-04-03 | 5 | $16M |
| TSRO | TESARO, Inc. | 10% owner · lapsed | 2016-03-18 → 2019-01-22 | 3 | $25M |
| CRCM | Care.com Inc | 10% owner · lapsed | 2017-11-08 → 2017-11-08 | 1 | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 10% owner · lapsed | 2017-10-04 → 2017-10-10 | 2 | — |
| ROKA | Roka BioScience, Inc. | 10% owner · lapsed | 2016-09-23 → 2016-09-30 | 2 | — |
| EPZM | Epizyme, Inc. | 10% owner · lapsed | 2016-01-12 → 2016-01-12 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BZFD | 2025-03-11 | Sell | 13,629 | $1.95 | $26,577 | 3,764,465 |
| BZFD | 2025-03-07 | Sell | 33,848 | $2.06 | $69,727 | 3,778,094 |
6 of 13 issuers are covered and open a security page; the rest are on file here only.
